Received Mar 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | X527B | — |
administration of an expired dose of Engerix-B; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-year-old female patient who received HBV (Engerix B) (batch number X527B, expiry date 17-MAR-2025) for prophylaxis. On 18-MAR-2025, the patient received Engerix B. On 18-MAR-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: administration of an expired dose of Engerix-B). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-MAR-2025 The healthcare professional called in to request data about the administration of an expired dose of Engerix-B. They stated the dose expired on March 17th, 2025, and was administered on March 18th, 2025, which led to expired vaccine used. They asked and doubled down on their wish to remain anonymous, but did consent to receive follow-up. The Vaccine Administration Facility is the same as Primary Reporter.